NCT01665807View on ClinicalTrials.gov

A Time-motion Study Comparing Self- to Nurse-vaccination With Influenza Vaccine

PHASE4CompletedINTERVENTIONAL
Enrollment

868

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
InfluenzaVaccination Site Reactions (HT)
Interventions
BIOLOGICAL

Intanza

Intanza influenza vaccine, trivalent split-virion, inactivated, approved for the 2012-2013 influenza season in northern hemisphere

BIOLOGICAL

Vaxigrip

Influenza vaccine, trivalent, split-virion, inactivated, approved for the 2012-2013 influenza season in the northern hemisphere

Trial Locations (2)

Unknown

Center for Vaccinology, Halifax

M5G1X5

Mount Sinai Hospital, Toronto

All Listed Sponsors
collaborator

Sanofi Pasteur, a Sanofi Company

INDUSTRY

lead

Brenda Coleman

OTHER

NCT01665807 - A Time-motion Study Comparing Self- to Nurse-vaccination With Influenza Vaccine | Biotech Hunter | Biotech Hunter